Matthew S Block相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma

帕博利珠单抗联合伊布替尼治疗不可切除或转移性黑色素瘤的 I 期研究

期刊:Frontiers in Immunology

影响因子:5.7

doi:10.3389/fimmu.2025.1491448

Yuan Yao, Yiyi Yan, Vera J Suman, Allan B Dietz, Courtney L Erskine, Anastasios Dimou, Svetomir N Markovic, Robert R McWilliams, Heather N Montane, Matthew S Block

发表日期：2025

文献求助收藏

Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial

新辅助治疗方案：cobimetinib 和 atezolizumab 联合或不联合 vemurafenib 用于高危可手术 III 期黑色素瘤：II 期 NeoACTIVATE 试验

期刊:Nature Communications

影响因子:14.7

doi:10.1038/s41467-024-45798-8

Tina J Hieken ，Garth D Nelson ，Thomas J Flotte ，Eric P Grewal ，Jun Chen ，Robert R McWilliams ，Lisa A Kottschade ，Lu Yang ，Evidio Domingo-Musibay ，Roxana S Dronca ，Yiyi Yan ，Svetomir N Markovic ，Anastasios Dimou ，Heather N Montane ，Courtney L Erskine ，Mara A Piltin ，Daniel L Price ，Samir S Khariwala ，Jane Hui ，Carrie A Strand ，Susan M Harrington ，Vera J Suman ，Haidong Dong ，Matthew S Block

发表日期：2024

文献求助收藏

Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors

单次静脉注射溶瘤腺病毒 TILT-123 可导致晚期实体瘤患者全身肿瘤转导和免疫反应

期刊:Journal of Experimental & Clinical Cancer Research

影响因子:11.4

doi:10.1186/s13046-024-03219-0

Elise Jirovec, Dafne C A Quixabeira, James H A Clubb, Santeri A Pakola, Tatiana Kudling, Victor Arias, Lyna Haybout, Katriina Jalkanen, Tuomo Alanko, Tine Monberg, Amir Khammari, Brigitte Dreno, Inge Marie Svane, Matthew S Block, Daniel A Adamo, Johanna Mäenpää, Claudia Kistler, Suvi Sorsa, Otto Hem

发表日期：2024

文献求助收藏

MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use

转移性黑色素瘤中 MOG 抗体相关疾病与免疫检查点抑制剂的使用相关

期刊:Neurology-Neuroimmunology & Neuroinflammation

影响因子:7.8

doi:10.1212/NXI.0000000000200249

Stephanie B Syc-Mazurek, Hannah Zhao-Fleming, Yong Guo, Nanthaya Tisavipat, John J Chen, Anastasia Zekeridou, Ioannis Kournoutas, Jacob J Orme, Matthew S Block, Claudia F Lucchinetti, Rafid Mustafa, Eoin P Flanagan

发表日期：2024

文献求助收藏

Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade

Th17 诱导树突状细胞疫苗可刺激卵巢癌产生有效的 CD4 T 细胞依赖性抗肿瘤免疫，从而克服对免疫检查点阻断的抵抗力

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.3

doi:10.1136/jitc-2023-007661

Yan Luo, Barath Shreeder, James W Jenkins, Huashan Shi, Purushottam Lamichhane, Kexun Zhou, Deborah A Bahr, Sophia Kurian, Katherine A Jones, Joshua I Daum, Navnita Dutta, Brian M Necela, Martin J Cannon, Matthew S Block, Keith L Knutson

树突状细胞

发表日期：2023

文献求助收藏

Convalescent Adaptive Immunity Is Highly Heterogenous after SARS-CoV-2 Infection

SARS-CoV-2 感染后的恢复期适应性免疫高度异质性

期刊:Journal of Clinical Medicine

doi:10.3390/jcm12227136

Balaji Pathakumari, Paige K Marty, Maleeha Shah, Virginia P Van Keulen, Courtney L Erskine, Matthew S Block, Pedro Arias-Sanchez, Patricio Escalante, Tobias Peikert

发表日期：2023

文献求助收藏

Convalescent Adaptive Immunity is Highly Heterogenous after SARS-CoV-2 Infection

SARS-CoV-2 感染后的恢复期适应性免疫具有高度异质性

doi:10.21203/rs.3.rs-3222112/v1

Paige K Marty, Balaji Pathakumari, Maleeha Shah, Virginia P Keulen, Courtney L Erskine, Matthew S Block, Pedro Arias-Sanchez, Patricio Escalante, Tobias Peikert

发表日期：2023

文献求助收藏

Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer

个性化肿瘤特异性 DNA 连接检测子宫内膜癌患者的循环肿瘤

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0252390

Tommaso Grassi, Faye R Harris, James B Smadbeck, Stephen J Murphy, Matthew S Block, Francesco Multinu, Janet L Schaefer Klein, Piyan Zhang, Giannoula Karagouga, Minetta C Liu, Alyssa Larish, Maureen A Lemens, Marla Kay S Sommerfield, Serena Cappuccio, John C Cheville, George Vasmatzis, Andrea Marian

子宫内膜癌

发表日期：2021

文献求助收藏

Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients

Th17 诱导自体树突状细胞疫苗接种促进卵巢癌患者抗原特异性细胞和体液免疫

期刊:Nature Communications

影响因子:14.7

doi:10.1038/s41467-020-18962-z

Matthew S Block, Allan B Dietz, Michael P Gustafson, Kimberly R Kalli, Courtney L Erskine, Bahaaeldin Youssef, Geraldine V Vijay, Jacob B Allred, Kevin D Pavelko, Michael A Strausbauch, Yi Lin, Megan E Grudem, Aminah Jatoi, Carolyn M Klampe, Andrea E Wahner-Hendrickson, S John Weroha, Gretchen E Gla

树突状细胞

发表日期：2020

文献求助收藏

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients

PD-1抑制剂治疗失败后，化疗联合免疫疗法可改善转移性黑色素瘤患者的临床疗效。

期刊:Melanoma Research

影响因子:1.5

doi:10.1097/CMR.0000000000000669

Jesus Vera Aguilera ，Jonas Paludo ，Robert R McWilliams ，Henan Zhang ，Ying Li ，Anagha B Kumar ，Jarrett Failing ，Lisa A Kottschade ，Matthew S Block ，Svetomir N Markovic ，Haidong Dong ，Roxana S Dronca ，Yiyi Yan

免疫/内分泌

发表日期：2020

文献求助收藏